相关实验视频

Updated: Jan 13, 2026

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

利用热致死来通过阿里皮普拉抑制黑色素瘤

Yu-Teng Chang^1,2,3, I-Hsiang Lin^4,5, Jeng-Jer Shieh^1,6,7,8,9

¹Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

Apoptosis : an international journal on programmed cell death

|January 10, 2026

概括

抗精神病药物阿里皮普拉通过激活caspase-1并释放炎症性细胞因子,在黑色素瘤细胞中触发编程细胞死亡 (pyroptosis). 这一发现突出了阿里皮普拉的重要性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

黑色素瘤对以亡为基础的疗法具有抗性,因此需要新的细胞死亡策略.
Pyroptosis是一种亲炎性编程细胞死亡途径,涉及caspase-1,gasdermin D和IL-1β.
阿里皮普拉是一种抗精神病药物,具有潜在的抗癌应用.

研究的目的:

研究阿里皮普拉诱导黑色素瘤细胞死亡的机制.
探索火和炎症信号在阿里皮普拉抗黑色素瘤作用中的作用.
为了确定关键的分子标,调解阿里皮普拉的抗癌活性.

主要方法:

用aripiprazole治疗的黑色素瘤细胞的转录组分析.
检测检测caspase-1激活,气皮素D裂变和细胞因子释放.
研究MAPK信号通路和细胞周期进展.
对NOD2表达和活性进行基因和药理学操纵.

主要成果:

阿里皮普拉在BRAF突变黑色素瘤细胞中诱导热,其特征是卡斯帕酶-1激活和IL-1β释放.
阿里皮普拉激活了MAPK信号级联,并导致G1细胞循环停止.
含有核酸结合寡合化域的蛋白2 (NOD2) 被阿里皮普拉升高调节,并被发现是诱导热的关键.
NOD2既调解了炎酶激活,也调解了下游信号通路 (MAPK,NF-κB).

结论:

阿里皮普拉通过NOD2-依赖的炎症信号传递有效地诱导黑色素瘤细胞中的热亡.
阿里皮普拉的抗癌作用包括热致死,MAPK激活和细胞循环停止.
像阿里皮普拉 (aripiprazole) 这样的血清增强药物显示出作为癌症治疗的免疫调节剂的前景.

关键词:

阿里皮普拉 (aripiprazole) 是一种药物.黑色素瘤是一种黑色素瘤.在NOD2中,NOD2是NOD2.热灭菌的发生.

更多相关视频

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...